U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Sold by Commerce Bank

Commerce Bank lowered its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH) by 3.2% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,328 shares of the company’s stock after selling 110 shares during the quarter. Commerce Bank’s holdings in U.S. Physical Therapy were worth $282,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the business. Renaissance Technologies LLC raised its position in U.S. Physical Therapy by 763.7% in the second quarter. Renaissance Technologies LLC now owns 69,523 shares of the company’s stock valued at $6,425,000 after purchasing an additional 61,474 shares during the period. Penn Davis Mcfarland Inc. acquired a new stake in shares of U.S. Physical Therapy in the third quarter valued at $2,552,000. Dimensional Fund Advisors LP raised its holdings in shares of U.S. Physical Therapy by 2.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 423,846 shares of the company’s stock valued at $39,173,000 after buying an additional 10,462 shares during the period. Vanguard Group Inc. raised its holdings in shares of U.S. Physical Therapy by 1.0% in the 1st quarter. Vanguard Group Inc. now owns 1,072,602 shares of the company’s stock valued at $121,065,000 after buying an additional 10,175 shares during the period. Finally, Envestnet Asset Management Inc. lifted its stake in U.S. Physical Therapy by 4.1% during the 2nd quarter. Envestnet Asset Management Inc. now owns 239,982 shares of the company’s stock worth $22,179,000 after acquiring an additional 9,434 shares in the last quarter.

U.S. Physical Therapy Price Performance

Shares of NYSE USPH opened at $97.08 on Thursday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The company has a market cap of $1.47 billion, a price-to-earnings ratio of 104.89, a price-to-earnings-growth ratio of 4.43 and a beta of 1.38. The stock’s 50-day moving average is $85.80 and its two-hundred day moving average is $90.53. U.S. Physical Therapy, Inc. has a 1-year low of $76.18 and a 1-year high of $113.63.

U.S. Physical Therapy Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 15th will be paid a dividend of $0.44 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.81%. U.S. Physical Therapy’s payout ratio is 187.23%.

Analysts Set New Price Targets

Several equities analysts have weighed in on USPH shares. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, August 21st. Bank of America restated a “neutral” rating and issued a $90.00 price objective (down previously from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th. Finally, Barrington Research reiterated an “outperform” rating and set a $108.00 target price on shares of U.S. Physical Therapy in a report on Thursday, November 21st.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, Director Kathleen A. Gilmartin bought 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were purchased at an average price of $86.09 per share, with a total value of $172,180.00. Following the completion of the acquisition, the director now directly owns 18,904 shares of the company’s stock, valued at $1,627,445.36. This represents a 11.83 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Graham D. Reeve sold 1,724 shares of the firm’s stock in a transaction on Friday, November 8th. The shares were sold at an average price of $96.29, for a total value of $166,003.96. Following the completion of the sale, the chief operating officer now owns 7,106 shares in the company, valued at approximately $684,236.74. This represents a 19.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 6,896 shares of company stock valued at $656,940 over the last 90 days. 1.70% of the stock is owned by corporate insiders.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.